SBI Life Stock Price: Buy SBI Life Insurance Company, Target Price Rs 1645: Emkay Global

Emkay Global has a call to buy with a target price of Rs 1645. The current market price of SBI Life Insurance Company is Rs 1162.75. The period given by the analyst is one year when . the price can reach the set target.

SBI Life Insurance Company Ltd., incorporated in 2000, is a large capitalization company (having a market capitalization of Rs 116413.12 Crore) operating in the financial services sector.

The main products/income segments of SBI Life Insurance Company Ltd. include the amount transferred from the policyholder’s account, interest, dividends and rents and profit/loss on the sale/redemption of investments for the year ending March 31, 2021.


For the quarter ended 31-03-2022, the company reported total standalone revenue of Rs 21666.15 Crore, up 4.76% from last quarter, total revenue of Rs 20681.58 Crore and in up 2.56% from the same quarter last year, total revenue of Rs 21,125.62 Crore. The company reported a net profit after tax of Rs 672.15 Crore last quarter.

Investment rationale
SBI LIFE recorded a 3-year CAGR RWRP of 18.1% in YTDFY23, with a CAGR of 14.6% for the private sector and a CAGR of 11.2% for the industry. The consistent outperformance helped SBILIFE increase its YTD RWRP market share to 15.0% in YTDFY23 from 12.5% ​​in YTDFY20. With all its distribution channels in operation, SBILIFE is perfectly executing its profitable growth plan.

Promoter/Fii Holdings
The promoters held 55.48% of the company’s capital as of March 31, 2022, while the FIIs held 24.15% and the DIIs 12.46%.

(Disclaimer: The recommendations given in this section or any report attached hereto are written by an external party. The views expressed are those of the respective authors/entities. These do not represent the views of Economic Times (ET). AND does not warrant, for, endorse any of its content and hereby disclaims all warranties, express or implied, relating thereto.Please consult your financial adviser and seek independent advice.


About Author

Comments are closed.